Critical evaluation of methods for determination of body fat content in children: back to basic parameters?

A Körner1, G Gelbrich, G Müller

  • 1University Hospital for Children & Adolescents, Leipzig, Germany.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|January 18, 2007
PubMed

Insights

Estimating body fat percentage (BF%) in children using different methods shows significant inconsistencies. Current field methods for assessing children's body composition lack reliability for comparative studies.

Area of Science:

  • Pediatric Endocrinology
  • Human Physiology
  • Biostatistics

Background:

  • Childhood obesity and related disorders are rising globally.
  • Accurate body fat assessment is crucial for pediatric research and clinical practice.

Purpose of the Study:

  • To evaluate the agreement between different methods for estimating body fat percentage (BF%) in prepubertal children.
  • To assess the reliability of various algorithms used for body fat calculation.

Main Methods:

  • Anthropometric measurements (BMI, skinfold thickness) and bioelectrical impedance analysis (BIA) were performed on 676 prepubertal Caucasian children.
  • Body fat percentage (BF%) was calculated using five distinct algorithms.
  • Raw centiles were established for each model.

Main Results:

  • Girls exhibited significantly higher BF% across all methods.
  • Significant discrepancies were observed between algorithms, with BIA-based equations yielding higher BF% than skinfold-based equations.
  • Inconsistencies and poor agreement (>10% BF% variation) were found among the algorithms, questioning their utility for comparative analysis.

Conclusions:

  • Body fat percentage estimation in children is highly dependent on the chosen method and algorithm.
  • The variability challenges the applicability of field methods for comparative body fat assessment in pediatric populations.
  • Basic parameters like BMI may offer more reliable comparative information than complex field methods.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...